Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2018 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces 2018 First Quarter Financial and Operational Results Release and Conference Call Date

LEXINGTON, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for...
April 04, 2018 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Granting of Inducement Awards

LEXINGTON, Mass., April 04, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for...
March 28, 2018 08:30 ET | Source: T2 Biosystems, Inc.

Multiple New Studies Demonstrate T2 Biosystems’ Diagnostics Improve Detection of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics

LEXINGTON, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products,...
March 19, 2018 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Present at the 17th Annual Needham Healthcare Conference

LEXINGTON, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for...
March 07, 2018 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Granting of Inducement Award

LEXINGTON, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for...
March 06, 2018 16:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update

LEXINGTON, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for...
March 06, 2018 07:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Awarded Up To $2 Million by CARB-X to Support Development of New Tests on the T2Dx Instrument for Drug-Resistant Bacteria

LEXINGTON, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for...
February 20, 2018 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces 2017 Fourth Quarter and Full-Year Financial and Operational Results Release and Conference Call Date

LEXINGTON, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for...
February 09, 2018 08:34 ET | Source: T2 Biosystems, Inc.

Two New Studies Demonstrate T2Candida’s Advantages over Current Diagnostic Testing

LEXINGTON, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare,...
February 06, 2018 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Present at the 7th Annual Leerink Partners Global Healthcare Conference

LEXINGTON, Mass., Feb. 06, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare,...